G01N 2333/70528
Cd58
G01N2333/70528 (Cd58) appears on 0 US grants and 4 published applications in this corpus.
Search patents in G01N- Granted patents
- 0
- Published applications
- 4
- Assignees
- 3
- Inventors
- 20
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Methods for diagnosing or treating health conditions or optimizing therapeutic efficacy of car-t cells therapies11 Sep 2025US 2025/0281532 A1The Board of Trustees of the Leland Stanford Junior University
- Method of enhancing immune response and cancer immunotherapy by targeting the cd58:cd2 axis26 Oct 2023US 2023/0340129 A1The Trustees of Columbia University in the City of New York
- Combinations of agents to treat hematological malignancies8 Sep 2022US 2022/0280519 A1Oregon Health & Science University
- Combinations of agents to treat hematological malignancies20 Feb 2020US 2020/0054639 A1Oregon Health & Science University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.